在减轻实验性牙周炎时对diosgenin剂量的评估和比较研究
Alper Kızıldağ1, Aysan Lektemür Alpan2, Tuğba Köseoğlu Aydın3
1Department of Periodontology, Faculty of Dentistry, Pamukkale University, Denizli, Turkey. alperkizildag@hotmail.com.
BMC oral health
|July 28, 2024
概括
迪奥斯基宁 (DG) 有效地减少了大鼠实验性牙周炎中的膜骨损失. 这种类固醇沙因表现出剂量依赖的治疗效果,促进骨形成和保护牙周组织.
科学领域:
- 牙周病学 牙周病学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 牙周炎是一种影响牙周组织的流行炎症性疾病.
- 膜骨损失 (ABL) 是晚期牙周炎的一个标志.
- 迪奥斯基宁 (DG) 是一种类固醇沙宁,正在研究其治疗潜力.
研究的目的:
- 评估迪奥斯基宁 (DG) 对大鼠实验性牙周炎诱导的膜骨损失 (ABL) 的治疗作用.
- 评估不同DG剂量对骨代谢和牙周组织保存的影响.
- 阐明DG在牙周炎方面的行动背后的分子机制.
主要方法:
- 实验性牙周炎在Wistar大鼠中使用带诱导.
- 鼠通过口服 gavage 接受不同的剂量DG (48和96毫克/公斤) 或安慰剂29天.
- 使用圆束计算断层扫描 (CBCT) 量化了膜骨损失.
- 免疫组织化学被用来分析骨形成标记物的表达 (OCN,ALP,Col-1,BMP-2),亡标记物 (Bcl-2,Bax) 和骨质细胞形成标记物 (RANKL).
主要成果:
- 在剂量依赖的方式,DG的管理显著降低了牙周炎的组织病理征兆.
- 治疗DG增加了骨形成标记物的表达 (ALP,OCN,Col-1,BMP-2) 和Bcl-2.
- DG降低了亲细胞亡的Bax和骨质细胞形成标志物RANKL的表达.
- 与牙周炎组相比,在接受DG治疗的组中观察到膜骨损失的显著减少.
结论:
- 狄奥斯基宁 (DG) 以剂量依赖的方式表现出显著的保护作用,防止牙周组织损伤.
- 通过调节关键分子通路,DG促进骨形成并抑制骨再吸收.
- 牙周炎的管理和预防膜骨损失代表了一种有前途的治疗策略.
更多相关视频
相关概念视频
Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...


